Pain is a universal experience. Common chronic pain conditions affect approximately 100 million U.S. adults at a cost of $560-635 billion annually in direct medical treatment costs and lost productivity.
Many shortfalls in pain assessment and treatment persist despite humanity’s intimate familiarity with pain throughout history, modern appreciation for the complexity of its origins and the diversity of its effects, and the substantial risk that any one person may have minor, serious, or chronic pain at some point in life. In general, these shortfalls arise through gaps in policy, treatment, attitudes, education, and research. Our mission is to aid in filling the gap in treatment of pain.
Throughout history one of the most widely used and accepted forms of treatment for the symptoms of chronic pain, as well as other conditions, has been the various uses of the Cannabis Hemp plant. In states permitting medical use more and more people are turning to Cannabis to ease their suffering. Scientist have discovered there is one key component of the Cannabis Hemp plant that accounts for most of the plant’s natural health benefits. That component is Cannabidiol (CBD). CBD is classified as a phytocannabinoid, another more familiar phytocannabinoid is THC, the component of Cannabis that causes the “high” commonly associated with the plant. On the contrary, CBD is not psychoactive as well as not habit forming or addictive. CBD can be derived from Industrial Hemp, Cannabis plants grown to contain less than 0.3% THC, making it available to all Americans regardless of laws restricting Cannabis in their respective states.